Princess Máxima Center has partnership with Academic Hospital Paramaribo

Date:
Maxima samenwerking Paramaribo

The Princess Máxima Center is partnering with the Academic Hospital Paramaribo (AZP) in Suriname. This collaboration, which began in 2023, aims to strengthen pediatric oncology care in Suriname.

Recently, Suriname opened its first-ever pediatric oncology treatment unit, but structured care for children with cancer is still new. The Máxima and AZP are committed to developing sustainable care options for children with cancer. Minke Huibers, pediatric oncology fellow, explains: ‘Every year, 20 to 30 children in Suriname are diagnosed with cancer. Until recently, these children had to go to Colombia for treatment. With the opening of a pediatric oncology center in Paramaribo, care can now be provided locally.’ However, this requires improvements in care, education, and diagnostics, which is where the collaboration with the Máxima Center comes in.

First pediatric oncologist in Suriname

The collaboration focuses on two key areas: care and education. Minke explains: ‘The Máxima Center supports AZP in improving treatment protocols and diagnostics. In addition, education plays a central role. Ritesh Matabadal started his pediatric oncology fellowship at the Princess Máxima Center this year. After 1.5 years, he will become the first pediatric oncologist in Suriname.’ Nurses are also being trained, led by pediatric oncology nurse Lisa Zwiers. The first group recently completed the basic training successfully, and a second group will finish in December. Most of the lessons are given online.

Equal opportunities worldwide

The Princess Máxima Center is the largest pediatric cancer center in Europe with an important mission: to cure every child with cancer, with optimal quality of life. Minke says: ‘This goal goes beyond the Dutch borders. Worldwide, and especially in low- and middle-income countries, survival rates for children with cancer are low. In the Netherlands, 1 in 4 children die with cancer; in countries like Suriname, the percentage is much higher.’ The Máxima Center is committed to equal opportunities worldwide and supports pediatric oncology projects in different countries. In line with our mission, we are working towards better care for every child with cancer, wherever they are in the world.

UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.

Hardloopsymposium

Are you participating in the Utrecht Marathon or are you a keen runner? Register for the Running Symposium on March 19th.

On Sunday, May 31st, Utrecht Science Park will once again be the setting for the Utrecht Marathon. Thousands of runners will line up at the starting line to achieve a fantastic feat: running a quarter, half, or full marathon! To help you prepare optimally, the Utrecht Science Park Foundation, in collaboration with partners Utrecht University, UMC Utrecht, Utrecht University of Applied Sciences, and Olympos Sports Centre, is organizing a running symposium where you’ll be informed and inspired to get the most out of your running performance.

utrechtinc validation program

Applications Now Open for UtrechtInc Validation Programmes

Have you ever wondered what it takes to turn research or an idea into a startup? The validation programmes offered by UtrechtInc may provide the first step. Applications are now open.

Utrecht Science Park researchers receive prestigious Cancer Grand Challenge grants

Several research groups, including researchers from UMC Utrecht, the Princess Máxima Center, and the Hubrecht Institute, have been selected for a prestigious Cancer Grand Challenge (CGC) grant. Cancer Grand Challenges was co-founded in 2020 by Cancer Research UK and the National Cancer Institute in the United States. The initiative supports international, multidisciplinary research teams focusing on major challenges in cancer research.